The purpose<\/strong> of this call for proposals<\/a> is to promote research focused on health outcomes by coordinating the research community around concrete, well-defined objectives that are relevant to specific diseases. The grant aims to promote research among emerging research groups from different autonomous communities, organized into a networked research project, by directing their research activities toward common objectives that will yield results applicable to the general population. <\/p>\n <\/p>\n This call for proposals<\/strong> is aimed at networked research projects<\/strong> comprising at least three research groups<\/strong>, led by principal investigators born in 1981 or later, whose scientific output indicates they have the potential to become highly competitive groups; these groups must submit a single proposal outlining a distinctive and innovative approach.<\/p>\n Research groups must be organized into a network coordinated by one of the participating principal investigators and must include groups from at least three different autonomous communities. The principal investigators of the participating research groups, including the coordinator, may submit only one proposal for a network project. <\/p>\n Structure:<\/strong><\/p>\n A network coordinator, who will serve as the point of contact with the AstraZeneca Foundation and will be responsible for the research group (principal investigator) leading the research project, as well as for coordinating among the various participating research groups to ensure the scientific program is carried out. Requirements:<\/strong><\/p>\n a) Establish a specific objective around which to structure the scientific project within the chosen subject area. (Full details are available in the call for proposals<\/a>)<\/p>\n <\/p>\n Proposals submitted under this call for proposals may only pertain to research projects conducted within the national territory and with a maximum duration Projects must fall within one of the research lines included in the following thematic areas:<\/p>\n 1) Cardiovascular, Renal, and Metabolic Disorders<\/strong> 2) Oncology, Precision Medicine, and Immuno-Oncology<\/strong> 3) Respiratory and Immunology<\/strong><\/p>\n Chronic Obstructive Pulmonary Disease (COPD) <\/p>\n The 10th edition of the AstraZeneca Foundation\u2019s Young Researchers Awards has a total budget of nine hundred fifty thousand euros (\u20ac950,000), to fund both collaborative projects and the Honorary Award for Excellence in Scientific Career and Outstanding Contribution to Public Health.<\/p>\n It is anticipated that up to four<\/strong> network research projects<\/strong> will be funded\u2014one for each<\/strong> eligible subject area<\/strong>, as specified in Rule 4 of this call for proposals\u2014provided they meet the requirements and conditions described in these guidelines. A total of two hundred twenty-five thousand euros (\u20ac225,000)<\/strong> will be allocated ,<\/strong> in a single payment, for each of the<\/strong> networked research projects<\/strong>, which will include, where applicable, indirect costs (overheads) for administrative management.<\/p>\n The award granted as part of the Honorary Award for Excellence<\/strong> in Scientific Career and Outstanding Contribution to Public Health will be in the amount of fifty thousand euros (50,000 \u20ac)<\/strong>.<\/p>\n <\/p>\n In the case of grants for networked research projects, interested parties may submit their applications along with the corresponding attachments electronically, via file attachments Applications must be submitted in Spanish<\/strong>; projects submitted in any other language will not be evaluated. The application must include the name and other identifying information The principal investigators in charge of the participating research groups, including the coordinator, may submit only one proposal for a network project. For its part, a coordinating entity may submit a maximum of two projects for each of the<\/strong> defined thematic areas<\/strong>, which will be accepted in strict order of submission. <\/p>\n<\/h3>\n
Research Groups<\/h3>\n
\n– One person responsible for each research group, who will serve as the group\u2019s principal investigator and act as its representative, and who will be responsible for ensuring that the work packages assigned to the group are completed.
\n– Research groups. Defined as a group of researchers who work under the direction of the principal investigator, publish jointly in their field of study, and coordinate their efforts in the development and implementation of the work packages assigned to them within the framework of the network project. <\/p>\n
\nb) Have a scientific project geared toward the objective that defines the network, organizing the participation of the various research groups, as well as appropriate performance indicators to assess the project\u2019s progress.
\nc) Be composed of at least three research groups belonging to public or private healthcare or university institutions, public research organizations, or other research centers throughout the country and from at least three different autonomous communities. There is no limit on the number of groups that may form the network, provided th
\n, each group meets the requirements defined in these Guidelines.
\nd) The principal investigators in charge of the participating research groups must have been born in 1981 or later, and one of them must serve as the network project coordinator <\/p>\nRequirements for Project Proposals<\/h3>\n
\nof 24 months. This period will begin once the grant funds have been disbursed. <\/p>\n
\n\u2022 Chronic Kidney Disease and Hyperkalemia
\n\u2022 Heart Failure
\n\u2022 Type 2 Diabetes Mellitus
\n\u2022 Transthyretin Amyloidosis (ATTR)<\/p>\n
\n\u2022 Lung Cancer
\n\u2022 Breast Cancer
\n\u2022 Ovarian Cancer
\n\u2022 Gastrointestinal Cancer
\n\u2022 Onco-hematology<\/p>\n
\n\u2022 Asthma
\n\u2022 Lupus
\n\u2022 Eosinophilic Inflammatory Diseases
\n\u2022 Chronic Rhinosinusitis with Nasal Polyposis
\n4) Infectious and Vaccine-Preventable Diseases
\n\u2022 Pediatric Influenza
\n\u2022 Respiratory Syncytial Virus (RSV)
\n\u2022 Metapneumovirus
\n\u2022 Clostridium difficile
\n\u2022 Pseudomonas aeruginosa<\/p>\nFunding<\/h3>\n
Submission of Applications and Deadline<\/h3>\n
\n(PDF), exclusively via the email address jovenes.investigadores@astrazeneca.com, and they may download the application form, which they must complete in order to
\nAnnouncement of the call for applications on the AstraZeneca Foundation’s website www.fundacionastrazeneca.es<\/a><\/p>\n
\nof the coordinator and the heads of the participating research groups. <\/p>\n